Press Releases
-
Apr 20, 2020Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus TreatmentCedars-Sinai-Developed ‘Healight' Medical Device Platform Technology Being Studied as a Potential First-in-Class COVID-19 Treatment...Apr 17, 2020Chinese Officials Confirm China Won't Restrict Exports of Medical Products Needed to Fight Coronavirus...Apr 16, 2020Independent clinical study demonstrates test accuracy of 98.0% and 94.1% for IgG and IgM, respectively, when using PCR-positive cases as true positives...Apr 15, 2020Company Places Third Purchase Order for One Million Tests...Apr 13, 2020ENGLEWOOD, CO / ACCESSWIRE / April 13, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today the launch of Regoxidine®, an over-the-counter foam formulation of minoxidil available for use by both men and women. Regoxidine® is indicated for hair treatment and regrowth and is a...Apr 9, 2020ENGLEWOOD, CO / ACCESSWIRE / April 9, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced that, due to Colorado's "shelter in place" order related to the Coronavirus Disease ("COVID-19") crisis, the Company has rescheduled the upcoming annual meeting of the stockhol...Apr 8, 2020Aytu BioScience Licensee SUDA Pharmaceuticals Expands ZolpiMist Global Footprint Through Exclusive Licensing Agreement with Mitsubishi Tanabe Pharma Corporation...Apr 7, 2020Cash and Cash Equivalents of Approximately $62.5 on March 31, 2020...Apr 6, 2020100,000 COVID-19 Rapid Tests Ready to Ship Across the Country with 500,000 More on the Way...Apr 3, 2020First COVID-19 Rapid Tests Delivered to Denver First Responders...